Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP15 | Q460N3 | 5/20 | 0.45 |
| ▸ | PARP10 | Q53GL7 | 5/20 | 0.45 |
| ▸ | PARP2 | Q9UGN5 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14805173 | 0.83 | CA1 (0.35) | ALDH1A1LMNAGAAPKM | |
| SCHEMBL19874475 | 0.80 | CA12 (0.44) | GAA | |
| SCHEMBL14805176 | 0.80 | CA12 (0.54) | ALDH1A1LMNAGAAPKMTDP1 | |
| SCHEMBL19874527 | 0.80 | CA12 (0.44) | GAA | |
| SCHEMBL18088499 | 0.79 | PKM (0.33) | ALDH1A1LMNAGAAPKM | |
| SCHEMBL19887232 | 0.78 | CA1 (0.39) | TDP1 | |
| SCHEMBL26812 | 0.77 | HTT (0.47) | ALDH1A1LMNAGAA | |
| SCHEMBL10823807 | 0.76 | CA1 (0.43) | ALDH1A1LMNAGAA | |
| SCHEMBL9498256 | 0.76 | ALDH1A1 (0.61) | ALDH1A1GAA | |
| SCHEMBL14797966 | 0.76 | CA12 (0.58) | ALDH1A1LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107406379-B | Non-explosive bis-sulfonyl azides | 戴纳米特诺贝尔爆炸材料和系统工程有限公司 | 2020-10-16 | — | — | CN | claimed |
| EP-3268352-B1 | NON EXPLOSIVE BIS-SULFONYL AZIDES | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF UND SYSTEMTECHNIK (DE) | 2020-06-10 | — | — | EP | claimed |
| US-10385016-B2 | Non explosive bis-sulfonyl azides | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) | 2019-08-20 | — | — | US | claimed |
| US-20180050988-A1 | NON EXPLOSIVE BIS-SULFONYL AZIDES | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF- UND SYSTEMTECHNIK (DE) | 2018-02-22 | — | — | US | claimed |
| CN-107406379-B | Non-explosive bis-sulfonyl azides | 戴纳米特诺贝尔爆炸材料和系统工程有限公司 | 2020-10-16 | — | — | CN | disclosed |
| EP-3268352-B1 | NON EXPLOSIVE BIS-SULFONYL AZIDES | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF UND SYSTEMTECHNIK (DE) | 2020-06-10 | — | — | EP | disclosed |
| EP-3268352-B1 | NON EXPLOSIVE BIS-SULFONYL AZIDES | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF UND SYSTEMTECHNIK (DE) | 2020-06-10 | — | — | EP | disclosed |
| US-10385016-B2 | Non explosive bis-sulfonyl azides | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) | 2019-08-20 | — | — | US | disclosed |
| US-10385016-B2 | Non explosive bis-sulfonyl azides | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF-UND SYSTEMTECHNIK (DE) | 2019-08-20 | — | — | US | disclosed |
| US-20180050988-A1 | NON EXPLOSIVE BIS-SULFONYL AZIDES | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF- UND SYSTEMTECHNIK (DE) | 2018-02-22 | — | — | US | disclosed |
| US-20180050988-A1 | NON EXPLOSIVE BIS-SULFONYL AZIDES | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF- UND SYSTEMTECHNIK (DE) | 2018-02-22 | — | — | US | disclosed |
| US-20180050988-A1 | NON EXPLOSIVE BIS-SULFONYL AZIDES | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF- UND SYSTEMTECHNIK (DE) | 2018-02-22 | — | — | US | disclosed |
| WO-2016146597-A1 | NON EXPLOSIVE BIS-SULFONYL AZIDES | DYNAMIT NOBEL GMBH EXPLOSIVSTOFF- UND SYSTEMTECHNIK (DE) | 2016-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10385016-B2 | Non explosive bis-sulfonyl azides | ARSA, MSRB3, NES | PARP15 509/4885PARP10 647/4885PARP2 349/4885 |
| US-20180050988-A1 | NON EXPLOSIVE BIS-SULFONYL AZIDES | ARSA, MSRB3, NES | PARP15 508/4885PARP10 653/4885PARP2 328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.